Teen, 15, Gets USB Cable Stuck Inside His Member Trying To Measure Length
An adolescent inserted the USB cable into his penis “to measure the length of his penis triggered by sexual curiosity.” (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 18, 2021 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news

Central Pacific Bank Foundation donates $250,000 to Kuakini Medical Center
“CPB Foundation is proud to recognize the vital role that Kuakini Medical Center has played in supporting the health care needs of Hawaii for more than a century,” said Keith Amemiya, CPB Foundation's executive director, in a statement. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 17, 2021 Category: Pharmaceuticals Authors: Brian McInnis Source Type: news

Bay Area biotechs soar on coattails of AstraZeneca cancer drug study
Shares of a Bay Area biotech company shot up more than 157% and another climbed to a lesser degree Friday after a Big Pharma company reported that a cancer drug with a shared target appeared effective in fighting tumors. Both Corvus Pharmaceuticals Inc. (Nasdaq: CRVS) of Burlingame and Arcus Biosciences Inc. (NYSE: RCUS) of Hayward shot up after AstraZeneca plc reported fresh data from a mid-stage clinical trial. That Big Pharma player said its already-approved cancer immunotherapy Imfinzi showed… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 17, 2021 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Bay Area biotechs soar on coattails of AstraZeneca cancer drug study
Shares of a Bay Area biotech company shot up more than 157% and another climbed to a lesser degree Friday after a Big Pharma company reported that a cancer drug with a shared target appeared effective in fighting tumors. Both Corvus Pharmaceuticals Inc. (Nasdaq: CRVS) of Burlingame and Arcus Biosciences Inc. (NYSE: RCUS) of Hayward shot up after AstraZeneca plc reported fresh data from a mid-stage clinical trial. That Big Pharma player said its already-approved cancer immunotherapy Imfinzi showed… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 17, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news

Whistleblower in Theranos founder's fraud trial testifies speed was valued over accuracy
The former lab technician who blew the whistle on Theranos wrapped up three days of testimony and cross-examination Friday in the fraud trial of Elizabeth Holmes. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 17, 2021 Category: Pharmaceuticals Authors: Cromwell Schubarth Source Type: news

FDA panel votes against Pfizer’s Covid-19 booster jab application
Advisory committee endorses third dose only for elderly and at-risk groups in blow to Biden (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 17, 2021 Category: Pharmaceuticals Source Type: news

UAB to adjust vaccine mandate following new federal rules
UAB will be making changes to its vaccine mandate in anticipation of new federal regulations. According to WBRC, the UAB Health System will remove its policy requiring Covid vaccinations for employees due to the recent executive order issued by President Joe Biden. UAB will end the requirement and replace its current policy based on guidance from upcoming federal rules, which will include mandatory vaccinations for employees of health care facilities receiving Medicare or Medicaid funds. "UAB… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 17, 2021 Category: Pharmaceuticals Authors: Tyler Patchen Source Type: news

Denver entrepreneur and design firm link up for new medical device
In addition to being designed in Denver, part of the device will be manufactured in the state. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 17, 2021 Category: Pharmaceuticals Authors: Jensen Werley Source Type: news

Failed drug trials and a merger lead to job cuts at Peninsula biotechs
More than 300 jobs are expected to be cut over the coming months at three Peninsula biotech companies. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 17, 2021 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Coronavirus latest: UK to begin rolling out antibody cocktail for hospitalised patients
(Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 17, 2021 Category: Pharmaceuticals Source Type: news

Coronavirus: UK to begin rolling out antibody cocktail for hospitalised patients — as it happened
(Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 17, 2021 Category: Pharmaceuticals Source Type: news

Health Groups on Philip Morris Move: 'Reprehensible'
Big Tobacco giant has scooped up UK pharma company Vectura, which makes asthma inhalers (Source: Reuters: Health)
Source: Reuters: Health - September 17, 2021 Category: Consumer Health News Source Type: news

Americans Are Poisoning Themselves In Large Numbers With Bleach, Hand Sanitizer And Quack Covid Cures Like Ivermectin
Poison control centers dealt with more cases of people abusing the antiparasitic ivermectin, which has been falsely touted as a Covid-19 cure, in August than they did for the whole of 2019 or 2020. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 17, 2021 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Editors' Pick editors-pick Dashboard Coronavirus Source Type: news

World’s largest vaccine maker optimistic on India easing export restrictions
Chief of Serum Institute criticises ‘unethical’ behaviour of wealthy nations pursuing Covid booster jabs (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 17, 2021 Category: Pharmaceuticals Source Type: news

Addressing data challenges to improve health equity
The COVID-19 pandemic has shed light on the ways that systemic racism pervades nearly every facet of life – especially within our health care system. The biopharmaceutical industry is dedicated to tackling these issues head-on and addressing health disparities that disproportionately affect communities of color and other underserved communities. Driven by this commitment, PhRMA is releasing a series o f papers thatidentify some of the challenges to improving health equity, potential solutions to those challenges and barriers to implementation and actionable steps to knock down those barriers. (Source: The Catalyst)
Source: The Catalyst - September 17, 2021 Category: Pharmaceuticals Authors: Emily Donaldson Tags: Research and Development Equity Source Type: news

Around 2 Million Die From Work-Related Causes Annually, Finds UN Report
As many as 1.9 million people died from work-related diseases and injuries in 2016, according to the first joint estimates from the World Health Organization (WHO) and International Labour Organization (ILO). The majority of work-related deaths were due to respiratory and cardiovascular disease. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 17, 2021 Category: Pharmaceuticals Authors: Disha Shetty, Contributor Tags: Science /science Innovation /innovation Healthcare /healthcare Source Type: news

Pandemic Middle Management: Balancing Patient and Staff Needs Pandemic Middle Management: Balancing Patient and Staff Needs
Managing from the middle has become more difficult during a pandemic as we balance caring for patients while also caring for our healthcare employees.Medscape Blogs (Source: Medscape Business of Medicine Headlines)
Source: Medscape Business of Medicine Headlines - September 17, 2021 Category: Pharmaceuticals Tags: Hospital Medicine Blog Source Type: news

Letting teens decide whether to get vaccinated is madness
The UK government’s confused handling of the situation has only fuelled distrust (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 17, 2021 Category: Pharmaceuticals Source Type: news

Huadong Medicine and PulseCath Announce Strategic Collaboration to Develop and Commercialize the iVAC mechanical circulatory product in Greater China
Partnership accelerates the development of the iVAC 2L mechanical circulatory device in Greater China. Expands Huadong Medicine's medical portfolio for cases of high-risk PCI with innovative percutaneous ventricle assist devices based on innovative puls... Devices, Interventional, Cardiology PulseCath, Huadong Medicine, iVAC 2L, mechanical circulatory device (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 17, 2021 Category: Pharmaceuticals Source Type: news

Novavax to test its Covid vaccine candidate in another UK trial
The trial will include hundreds of adolescents. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 17, 2021 Category: Pharmaceuticals Authors: Rebecca Cooper Source Type: news

Janssen Presents Results from Phase 1b/2 NORSE Study in Patients with Metastatic or Locally Advanced Urothelial Carcinoma Treated with BALVERSA ® (erdafitinib) in Combination with Cetrelimab, a PD-1 Inhibitor
September 17, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the Phase 1b/2 NORSE (NCT03473743) study evaluating BALVERSA® (erdafitinib) in combination with cetrelimab, an anti-programmed cell death protein 1 (PD-1) monoclonal antibody, compared to BALVERSA® monotherapy in patients with locally advanced or metastatic urothelial carcinoma (mUC) with fibroblast growth factor receptor (FGFR)3 or FGFR2 genetic alterations who are ineligible for cisplatin, a current standard of care treatment for mUC. The results were highlighted in an oral present...
Source: Johnson and Johnson - September 17, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

More than 30 VC firms have a presence in Nashville, third-highest tally among Southeast cities across 10 states
The Southeast Capital Landscape Report is made for entrepreneurs and intended to be a directory of investors across 10 states in the Southeast. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 17, 2021 Category: Pharmaceuticals Authors: Adam Sichko Source Type: news

Kids & Covid: What You Need To Know About Schools, Vaccines, And Risk
Covid cases among children are on the rises, with many new cases linked to outbreaks of the Delta variant in schools. Here's what we can do about it. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 17, 2021 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news

KSL Biomedical expands through acquisition of Ontario's Pulse Scientific
The acquisition takes the fast-growing biotech company into the Canadian market – and hastens its ability to expand around the world. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 17, 2021 Category: Pharmaceuticals Authors: Tracey Drury Source Type: news

Roche receives positive CHMP opinion for Gavreto ® (pralsetinib) for the treatment of adults with RET fusion-positive advanced non-small cell lung cancer
Basel, 17 September 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency ’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Gavreto® (pralsetinib) as a monotherapy for the treatment of adult patients with rearranged during transfection (RET) fusion-positive advanced non-small cell lung cancer (NSCLC) not previously treated w ith a RET inhibitor. (Source: Roche Media News)
Source: Roche Media News - September 17, 2021 Category: Pharmaceuticals Source Type: news

Roche receives positive CHMP opinion for Gavreto ® (pralsetinib) for the treatment of adults with RET fusion-positive advanced non-small cell lung cancer
Basel, 17 September 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency ’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Gavreto® (pralsetinib) as a monotherapy for the treatment of adult patients with rearranged during transfection (RET) fusion-positive advanced non-small cell lung cancer (NSCLC) not previously treated w ith a RET inhibitor. (Source: Roche Investor Update)
Source: Roche Investor Update - September 17, 2021 Category: Pharmaceuticals Source Type: news

Long Covid Less Common Than Feared As Studies Suggest Many Confuse Other Symptoms With Condition
Common ailments like fever, fatigue, muscle aches and headaches might be being confused for symptoms of long Covid, studies have found. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 17, 2021 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Editors' Pick editors-pick Coronavirus Source Type: news

Power 10: Brian Pieninck, CareFirst BlueCross BlueShield
Pieninck has now been at the helm of CareFirst since July 2018, overseeing an organization that employs more than 7,000 and serves about 3.5 million customers in the mid-Atlantic region. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 17, 2021 Category: Pharmaceuticals Authors: Morgan Eichensehr Source Type: news

The List: Austin-area life science companies
The 2021 list of Austin-area life science companies is a broad list of forward-thinking businesses that contribute to advancing health care science, products and services. The list highlights a local, diverse group across the spectrum of improving health and diagnostics. Listmakers includes pharmaceuticals, cell therapies, implants, medical devices, biological diagnostics and patient care software. Companies represented range from large contract research organizations (CROs) to local startups conducting internal R&D for proprietary products. ABJ surveys companies annually. Only companies that responded to requests for ...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 17, 2021 Category: Pharmaceuticals Source Type: news

The life-saving medicine that is killing the planet
Even with good disclosures and determination, cutting carbon emissions is hard (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 17, 2021 Category: Pharmaceuticals Source Type: news

Charlotte developer buys former church site in Triad, plans project
A Charlotte developer will soon bring new development to a Triad site on a busy commercial corridor. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 17, 2021 Category: Pharmaceuticals Authors: John Brasier Source Type: news

'Hardcore group of 20%' won't get vaccinated, new Kentucky poll shows
The Foundation for a Healthy Kentucky released results for a new poll that reflects attitudes about the Covid-19 vaccine in the state. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 17, 2021 Category: Pharmaceuticals Authors: Chris Larson Source Type: news

Behind the deal: How North Carolina beat Texas for Fujifilm's $2B, 725-job project
It wasn ’t just public officials rallying. Emails show folks from Duke Energy Corp. and the North Carolina Biotechnology Association, too, were in contact — an all-hands effort to secure the project. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 17, 2021 Category: Pharmaceuticals Authors: Lauren Ohnesorge Source Type: news

Form D Friday: Tiger Global bets another $50M on robotics unicorn
Form D Friday is a Boston Business Journal feature highlighting regulatory filings from Boston-area companies raising capital for new projects or expanding their businesses. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 17, 2021 Category: Pharmaceuticals Authors: Lucia Maffei Source Type: news

List analysis: Retirement communities in Wichita focus on recruiting amid staffing shortages
In a competitive job market, retirement communities are working harder to recruit workers with sign-on bonuses and higher wages. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 17, 2021 Category: Pharmaceuticals Authors: Shelby Kellerman Source Type: news

FDA panel to weigh boosters for Pfizer’s Covid-19 vaccine
Advisory committee will debate controversial proposal after data showing protection from mRNA shots can wane (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 17, 2021 Category: Pharmaceuticals Source Type: news

Roche opens access to pathology imaging tools to improve patient care
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the introduction of the Roche Digital Pathology Open Environment that allows software developers to easily integrate their image analysis tools for tumour tissue with Roche's uPath enterprise software, an application for pathologist workflow. This open environment allows for the secure exchange and flow of data so that pathologists can access advanced algorithms from third parties alongside Roche's menu of artificial intelligence-based image analysis tools. (Source: World Pharma News)
Source: World Pharma News - September 17, 2021 Category: Pharmaceuticals Tags: Featured Roche Business and Industry Source Type: news

Roche presents first phase II data on giredestrant, a next generation selective oestrogen receptor degrader, in untreated oestrogen receptor (ER)-positive, early breast cancer
Basel, 17 September 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced interim data from the randomised phase II coopERA Breast Cancer trial evaluating neoadjuvant treatment with giredestrant (formerly known as GDC-9545), an investigational next generation oral selective oestrogen receptor degrader (SERD), in post-menopausal women with ER-positive, HER2-negative early breast cancer. In the window of opportunity phase, after 14 days of treatment, giredestrant showed a reduction in Ki67, a prognostic marker that measures tumour proliferation, compared to anastrozole (80% versus 67% respectively, p=0.0222). The safety ...
Source: Roche Investor Update - September 17, 2021 Category: Pharmaceuticals Source Type: news

Pfizer and Moderna investors brace for eventual drop in vaccine sales
Analysts predict revenues from Covid-19 jabs will fall precipitously by 2024 (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 17, 2021 Category: Pharmaceuticals Source Type: news

How to tackle vaccine hesitancy
Not every unvaccinated person believes Covid-19 jabs are a genocidal conspiracy (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 17, 2021 Category: Pharmaceuticals Source Type: news

Hawaii Dental Service names new CEO
The new CEO succeeds Mark Yamakawa, who is retiring. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 17, 2021 Category: Pharmaceuticals Authors: Brian McInnis Source Type: news

Poll: Majority Of Americans Favor Covid-19 Vaccine And Face Mask Requirements
The poll found that 66% of those in "blue states" and 59% in "red states" favored “instituting, or reinstituting, state-based face mask and social distancing guidelines.” (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 17, 2021 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news

U.S. Seeks to Block Bankruptcy Plan That Would Free Sacklers From Opioid Claims
The Justice Department has been appealing the deal, approved earlier this month. (Source: NYT Health)
Source: NYT Health - September 17, 2021 Category: Consumer Health News Authors: Katie Benner Tags: Suits and Litigation (Civil) Pain-Relieving Drugs Bankruptcies OxyContin (Drug) Justice Department Purdue Pharma Drain, Robert D Sackler Family Source Type: news

Inno Under 25: Jamie Longacre: Wave Strategy
Wave Strategy is a biotech advisory firm that was started in response to the need for more rapid commercialization in the healthcare space. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 17, 2021 Category: Pharmaceuticals Authors: Mary Vanac Source Type: news

Kiran Mazumdar-Shaw & Adar Poonawalla spell out the road map for Biocon-Serum alliance
"The Biocon-Serum alliance will initially focus on Covid vaccines, because that is the need of the hour. At a later stage, we will see what makes the most global impact, what has the most value. After that, we'll jointly decide on what those vaccines should be." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 17, 2021 Category: Pharmaceuticals Source Type: news

Biocon unit plans 15% stake sale to Serum Institute for access to vaccines
The deal with Serum Institute Life Sciences values Biocon Biologics at about $4.9 billion and will solely focus on COVID-19 vaccines in the initial years, the companies said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 17, 2021 Category: Pharmaceuticals Source Type: news

Bharat Biotech awaits feedback from WHO for Covaxin EUL
The WHO is currently reviewing the data submitted by the vaccine maker and the date for a decision on the jab is yet "to be confirmed," according to the update available on WHO website. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 17, 2021 Category: Pharmaceuticals Source Type: news

Biocon Biologics, Serum Institute Life Sciences to expand tie-up for R & D, new vaccines
On Thursday, Biocon had said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about Rs36000 crore ($4.9 billion) where 15% will be valued at about Rs5100 crore. Post transaction, Biocon Ltd will hold 74.89% stake in Biocon Biologics. Serum Institute Life Sciences (SILS) is a subsidiary of Serum Institute of India (SII). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 17, 2021 Category: Pharmaceuticals Source Type: news

Indemnity issues may hold up availability of J & J single dose vaccine
While the drug regulator has given a nod to Biological E to manufacture the vaccine at its plant in Telangana, its launch looks unlikely till the government resolves the indemnity issue. “The discussions between the government and the company are ongoing and there is no conclusion yet on the indemnity issue,” said a senior government official on the condition of anonymity. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 17, 2021 Category: Pharmaceuticals Source Type: news

Texas allergy company partners with Valley practice to make Arizona debut
Phoenix-based Allergy Associates and Asthma Ltd. (AAA), which has multiple locations in the Valley, has teamed up with a national company to bring new treatments to its patients. The partnership will be the Arizona debut for Aspire Allergy& Sinus, which is based in Austin, Texas, and now has nearly 60 clinics in five states. The company is known for developing treatments such as allergy drops, ExACT Immunoplasty for environmental, household, and seasonal allergies, and oral immunotherapy for food … (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 16, 2021 Category: Pharmaceuticals Authors: Jeff Gifford Source Type: news